277
Views
22
CrossRef citations to date
0
Altmetric
Original Articles

Bayesian and likelihood inference for cure rates based on defective inverse Gaussian regression models

, &
Pages 127-144 | Received 03 Oct 2008, Accepted 01 Sep 2009, Published online: 12 Aug 2010
 

Abstract

Failure time models are considered when there is a subpopulation of individuals that is immune, or not susceptible, to an event of interest. Such models are of considerable interest in biostatistics. The most common approach is to postulate a proportion p of immunes or long-term survivors and to use a mixture model [5]. This paper introduces the defective inverse Gaussian model as a cure model and examines the use of the Gibbs sampler together with a data augmentation algorithm to study Bayesian inferences both for the cured fraction and the regression parameters. The results of the Bayesian and likelihood approaches are illustrated on two real data sets.

Acknowledgements

We are grateful to two anonymous referees for a number of constructive criticisms which helped to improve this manuscript.

This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC). Specifically, in the form of a scholarship to the first author and respective Discovery Grants to the second and third authors.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 549.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.